Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-24

FDA Approved: ALVIMOPAN — Original Application (Par Health USA, LLC)

View source ↗

Summary

The FDA approved Par Health USA, LLC's original ANDA for ALVIMOPAN, granting a generic version of alvimopan. The approval makes ALVIMOPAN available as a generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alvimopan (alvimopan)

Snippet

ORIG AP for ALVIMOPAN (ALVIMOPAN)